Join us for a poster highlight of the top abstracts from the Liver Transplantation and Surgery (LT&S) SIG. 
 

This interactive, joint AASLD and Society on Liver Disease in Africa (SOLDA) community conversation explores the global epidemiology of DILI and regional differences in its etiology. Needs associated with DILI and associated registries are identified. Through case presentations, panelists illustrate unique features of etiologies of DILI in Africa and highlight differences in diagnostic strategies and management. Presenters also review DILI survey data from Africa and identify DILI-related research gaps. The session aims to formulate strategies to overcome DILI managment challenges and advance DILI-related research in Africa. 

Continuing the successful AASLD-KASL collaboration underway since 2023, this session highlights practice-changing innovations in hepatology from leading researchers in the U.S. and Korea. Topics include the application of artificial intelligence for non-invasive assessment of liver fibrosis in patients with MASLD, the use of speech pattern analysis as a digital biomarker for detecting hepatic encephalopathy, clinical data on autologous bone marrow-derived mesenchymal stem cell transplantation for liver cirrhosis, and AI-powered tools that synthesize clinical guidelines to support real-time decision-making. A panel discussion will follow to explore the clinical impact, implementation challenges, and global relevance of these emerging technologies.

Join us for a poster highlight of the top abstracts from the Liver Fibrosis SIG. 
 

Join us for a poster highlight of the top abstracts from the Pediatric Liver Disorders (PLD) SIG. 
 

This session on alcohol-associated liver disease (ALD) provides a comprehensive overview from both patient and physician perspectives, emphasizing early detection, equitable access to treatment, and inclusive research practices. The session includes a patient sharing their experiences, highlighting the physical and emotional challenges of living with ALD and the importance of support systems. Physicians discuss early detection, detailing diagnostic tools and the benefits of early intervention. They also address how disparities influence access to liver transplantation and clinical trial opportunities, and propose strategies that center on equity. After the individual presentations, a panel of speakers answer questions from the audience and engage in a dialogue about the future directions in ALD detection, treatment, and research. 

Developed by the Patient Advisory Group, this session focuses on types of palliative care throughout various stages of liver disease, and how palliative care can be helpful for both patients with liver disease and their caregivers.

The central conflict in the conversation about liver transplants for patients with Alcohol-Associated Liver Disease (ALD) is the stark clash between medical ethics and moral judgment. Critics argue these patients are "undeserving" because their illness is perceived as "self-inflicted," suggesting they shouldn't compete for scarce organs with "blameless" individuals. We will talk to these patients and see how they navigate these murky waters when confronted with these issues.

Zoom:https://us06web.zoom.us/j/81878086913?pwd=Sum5bOxh4xtwZQ5zwRUd8FZJbXqYXA.1 

Explore the metabolic connections between obesity, MASLD/MASH, and cardiometabolic diseases, and how incorporating obesity care in hepatology practice can improve multiple health outcomes. Join expert clinicians for an in-depth discussion on the vital role of hepatology in obesity care and the importance of collaborative care.

Industry Supporter:: Boehringer Ingelheim Pharmaceuticals, Inc.